A Randomized Trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE)
Cerebrovascular Diseases · 29.08.2024 · 54 (4) · 559-566
DOI: 10.1159/000540606 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cerebrovascular Diseases, online erschienen am 29.08.2024. Verfasst von Pol Camps-Renom und 28 weiteren Autor:innen. Beteiligte Einrichtung: Stroke Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona, Spain. Hauptthemen laut MEDLINE: Endovascular Procedures, Cerebrovascular Circulation, Ischemic Stroke, Hemodynamics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
In patients with acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion, optimal blood pressure (BP) management following endovascular treatment (EVT) has not yet been established. The randomized trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE) (clinicaltrials.gov id: NCT04892511) aims to demonstrate whether hemodynamic optimization using different systolic BP targets following EVT according to the degree of final recanalization, is more effective than currently recommended BP management in improving functional outcomes of patients with AIS.
Methods
HOPE is an investigator-initiated multicenter clinical trial with randomized allocation, open-label treatment, and blinded endpoint evaluation (PROBE). Patients with an anterior circulation AIS within 24 h of symptom onset, treated with EVT, and showing successful recanalization (mTICI ≥2b) at the end of the procedure, are equally allocated (1:1) to hemodynamic optimization according to the study protocol versus BP management according to current guidelines (≤180/105 mm Hg). The protocol includes two different targets of systolic BP depending on the recanalization status (mTICI = 2b: 140–160 mm Hg; mTICI = 2c/3: 100–140 mm Hg). The protocol is applied within the first 72 h and includes BP lowering as well as vasopressor therapies when needed. The primary outcome is the proportion of favorable outcome (modified Rankin Scale [mRS] 0–2) at 90 days. Secondary outcomes include the shift on the mRS score, neurological deterioration, symptomatic intracerebral hemorrhage, and mortality.
Conclusion
The HOPE trial will provide new information on the safety and efficacy of different BP targets following EVT according to the degree of final recanalization in patients with AIS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stroke Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona, Spain.
- Stroke Unit, Department of Neurology, Hospital Dr. Josep Trueta, Girona, Spain.
- Stroke Unit, Hospital Universitario La Fe, Valencia, Spain.
- Stroke Unit, Department of Neurology, Hospital del Mar, Neurovascular Research Group, Hospital del Mar Research Institute, Barcelona, Spain.
- Stroke Unit, Department of Neurology, Hospital Universitari de Tarragona Joan XXIII, Institut d'Investigació Sanitaria Pere Virgili, Tarragona, Spain.
- Stroke Unit, Department of Neurology, Hospital General Universitario de Alicante, Alicante, Spain.
Zitieren
APA
Camps-Renom, P., Guasch-Jiménez, M., Martínez-Domeño, A., Prats-Sánchez, L., Ramos-Pachón, A., Álvarez-Cienfuegos, J., Silva, Y., Fortea-Cabo, G., Morales-Caba, L., Rodríguez-Campello, A., Giralt-Steinhauer, E., Flores, A., Ustrell, X., López-Hernández, N., Corona-García, D. J., Freijo-Guerrero, M. M., Luna, A., Tejada-Meza, H., Marta-Moreno, J., …, & Martí-Fàbregas, J. (2024). A Randomized Trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE). Cerebrovascular Diseases, 54(4), 559-566. https://doi.org/10.1159/000540606
Vancouver
Camps-Renom P, Guasch-Jiménez M, Martínez-Domeño A, Prats-Sánchez L, Ramos-Pachón A, Álvarez-Cienfuegos J, et al. A Randomized Trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE). Cerebrovascular Diseases. 2024;54(4):559-566. doi:10.1159/000540606
BibTeX
@article{CampsRenom2024,
author = {Camps-Renom, Pol and Guasch-Jiménez, Marina and Martínez-Domeño, Alejandro and Prats-Sánchez, Luis and Ramos-Pachón, Anna and Álvarez-Cienfuegos, Juan and Silva, Yolanda and Fortea-Cabo, Gerardo and Morales-Caba, Luis and Rodríguez-Campello, Ana and Giralt-Steinhauer, Eva and Flores, Alan and Ustrell, Xavier and López-Hernández, Nicolás and Corona-García, Diego José and Freijo-Guerrero, Mari Mar and Luna, Alain and Tejada-Meza, Herbert and Marta-Moreno, Javier and Moniche, Francisco and Pardo-Galiana, Blanca and Castellanos, Mar and Albert-Lacal, Laura and Sanz-Monllor, Ainara and Aguilera-Simón, Ana and Marín, Rebeca and Ezcurra-Díaz, Garbiñe and Lambea-Gil, Álvaro and Martí-Fàbregas, Joan},
title = {A Randomized Trial on Hemodynamic Optimization of Cerebral Perfusion after Successful Endovascular Therapy in Patients with Acute Ischemic Stroke (HOPE)},
journal = {Cerebrovascular Diseases},
year = {2024},
volume = {54},
number = {4},
pages = {559--566},
doi = {10.1159/000540606}
}
EUVIMED